Cargando…
Efficacy and Safety of Blood Derivative Therapy for Patients with COVID-19: A Systematic Review and Meta-Analysis
BACKGROUND: The outbreak of COVID-19 has resulted in more than 200 million infections and 4 million deaths. The blood derivative therapy represented by intravenous immunoglobulin (IVIG) and convalescent plasma (CP) therapy may be the promising therapeutics for COVID-19. METHODS: A systematic article...
Autores principales: | Fei, Zhangcheng, Chen, Zhongsheng, Du, Xi, Cao, Haijun, Li, Changqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148901/ https://www.ncbi.nlm.nih.gov/pubmed/35665313 http://dx.doi.org/10.1159/000524125 |
Ejemplares similares
-
Efficacy and safety of blood derivatives therapy in Alzheimer’s disease: a systematic review and meta-analysis
por: Fei, Zhangcheng, et al.
Publicado: (2022) -
Efficacy and safety of steroid therapy in COVID-19: A rapid systematic review and Meta-analysis
por: Sarma, Phulen, et al.
Publicado: (2020) -
Efficacy and safety of belimumab therapy in lupus nephritis: a systematic review and meta-analysis
por: Zhang, Han, et al.
Publicado: (2023) -
The Efficacy and Safety of Celecoxib in Addition to Standard Cancer Therapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Ye, Shi-Yu, et al.
Publicado: (2022) -
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis
por: Tleyjeh, Imad M., et al.
Publicado: (2021)